Hsing AW - Search Results

1

A genome-wide association study of prostate cancer in West African men.

Cook MB, Wang Z, Yeboah ED, Tettey Y, Biritwum RB, Adjei AA, Tay E, Truelove A, Niwa S, Chung CC, Chokkalingam AP, Chu LW, Yeager M, Hutchinson A, Yu K, Rand KA, Haiman CA; African Ancestry Prostate Cancer GWAS Consortium; Hoover RN, Hsing AW, Chanock SJ. Cook MB, et al. Among authors: hsing aw. Hum Genet. 2014 May;133(5):509-21. doi: 10.1007/s00439-013-1387-z. Epub 2013 Nov 2. Hum Genet. 2014. PMID: 24185611 Free PMC article.

2

Oral contraceptives and primary liver cancer among young women.

Hsing AW, Hoover RN, McLaughlin JK, Co-Chien HT, Wacholder S, Blot WJ, Fraumeni JF Jr. Hsing AW, et al. Cancer Causes Control. 1992 Jan;3(1):43-8. doi: 10.1007/BF00051911. Cancer Causes Control. 1992. PMID: 1536912

3

Parity and primary liver cancer among young women.

Hsing AW, McLaughlin JK, Hoover RN, Co Chien HT, Blot WJ, Fraumeni JF Jr. Hsing AW, et al. J Natl Cancer Inst. 1992 Jul 15;84(14):1118-9. doi: 10.1093/jnci/84.14.1118. J Natl Cancer Inst. 1992. PMID: 1619686

4

Occupation and prostate cancer risk in Sweden.

Sharma-Wagner S, Chokkalingam AP, Malker HS, Stone BJ, McLaughlin JK, Hsing AW. Sharma-Wagner S, et al. Among authors: hsing aw. J Occup Environ Med. 2000 May;42(5):517-25. doi: 10.1097/00043764-200005000-00010. J Occup Environ Med. 2000. PMID: 10824305

5

Insulin-like growth factors and prostate cancer: a population-based case-control study in China.

Chokkalingam AP, Pollak M, Fillmore CM, Gao YT, Stanczyk FZ, Deng J, Sesterhenn IA, Mostofi FK, Fears TR, Madigan MP, Ziegler RG, Fraumeni JF Jr, Hsing AW. Chokkalingam AP, et al. Among authors: hsing aw. Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):421-7. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11352850

6

Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in China.

Chokkalingam AP, McGlynn KA, Gao YT, Pollak M, Deng J, Sesterhenn IA, Mostofi FK, Fraumeni JF Jr, Hsing AW. Chokkalingam AP, et al. Among authors: hsing aw. Cancer Res. 2001 Jun 1;61(11):4333-6. Cancer Res. 2001. PMID: 11389055

7

Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.

Hsing AW, Chen C, Chokkalingam AP, Gao YT, Dightman DA, Nguyen HT, Deng J, Cheng J, Sesterhenn IA, Mostofi FK, Stanczyk FZ, Reichardt JK. Hsing AW, et al. Cancer Epidemiol Biomarkers Prev. 2001 Oct;10(10):1077-82. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11588134

8

Hormones and prostate cancer: what's next?

Hsing AW. Hsing AW. Epidemiol Rev. 2001;23(1):42-58. doi: 10.1093/oxfordjournals.epirev.a000795. Epidemiol Rev. 2001. PMID: 11588854 Review.

9

Hormones and prostate cancer: current perspectives and future directions.

Hsing AW, Reichardt JK, Stanczyk FZ. Hsing AW, et al. Prostate. 2002 Aug 1;52(3):213-35. doi: 10.1002/pros.10108. Prostate. 2002. PMID: 12111697 Review.

10

CYP17 polymorphisms in relation to risks of prostate cancer and benign prostatic hyperplasia: a population-based study in China.

Madigan MP, Gao YT, Deng J, Pfeiffer RM, Chang BL, Zheng S, Meyers DA, Stanczyk FZ, Xu J, Hsing AW. Madigan MP, et al. Among authors: hsing aw. Int J Cancer. 2003 Nov 1;107(2):271-5. doi: 10.1002/ijc.11378. Int J Cancer. 2003. PMID: 12949806 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

326 results

Search Page

Filters